Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand Obese mice with type 2 diabetes
- 16 December 2009
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 85 (23-26), 775-781
- https://doi.org/10.1016/j.lfs.2009.10.014
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Modulation of p‐glycoprotein function by caveolin‐1 phosphorylationJournal of Neurochemistry, 2007
- Tumor Necrosis Factor α and Endothelin-1 Increase P-Glycoprotein Expression and Transport Activity at the Blood-Brain BarrierPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- Diabetic Mouse Angiopathy Is Linked to Progressive Sympathetic Receptor Deletion Coupled to an Enhanced Caveolin-1 ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissueAmerican Journal of Physiology-Cell Physiology, 2003
- NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cellsOncogene, 2003
- Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cellsCellular and Molecular Life Sciences, 2001
- P‐glycoprotein is localized in caveolae in resistant cells and in brain capillariesFEBS Letters, 2000
- Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes.JCI Insight, 1994
- Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.Proceedings of the National Academy of Sciences of the United States of America, 1989
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986